Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

PDX imaging models in brain tumours

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 11.05.18
Views: 412
Rating:

Prof Kevin Brindle - Cancer Research UK Cambridge Institute, Cambridge, UK

Prof Brindle talks to ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about the use of PDX imaging models in brain tumours.

He discusses a new metabolic imaging technique that improves sensitivity of magnetic resonance.

He goes on to talk about pharmacokinetics and pharmacodynamics and how the new imaging technique can tell if drugs have crossed the blood-brain barrier and reached the target site or not.
 

Related videos

follow us

War on Cancer 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation